Fig. 2From: Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetesConsort flow chart. The figure shows the consort flow chart according to ITT analysisBack to article page